Periorbital edema associated with alpelisib

Periorbital edema associated with alpelisib

Alpelisib is an alpha isoform-specific phosphatidylinositol 3-kinase (PI3K) inhibitor approved for use in the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor (HER2)-negative metastatic breast cancer in combination with fulvestrant. Hyperglycemia, rash, and gastroi...

Full description

Bibliographic Details
Main Authors: Elizabeth A. Dao, Saira J. George, Meghan M. Heberton, Omar Pacha, Craig A. Kovitz, Anisha B. Patel, Rhea M. Phillips
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Alpelisib
Phosphatidylinositol 3-kinase inhibitors
Cutaneous adverse events
Breast cancer
Dermatology
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294222000867

Internet

http://www.sciencedirect.com/science/article/pii/S2468294222000867

Similar Items